SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-11-219730
Filing Date
2011-08-11
Accepted
2011-08-11 16:55:58
Documents
6
Period of Report
2011-08-11
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d8k.htm 8-K 21821
2 OPINION OF COOLEY LLP. dex51.htm EX-5.1 5706
3 SALES AGREEMENT, DATED AUGUST 11, 2011 dex101.htm EX-10.1 163799
4 PRESS RELEASE dex991.htm EX-99.1 77600
5 GRAPHIC g220493g14z82.jpg GRAPHIC 6498
6 GRAPHIC g220493g32n71.jpg GRAPHIC 15364
  Complete submission text file 0001193125-11-219730.txt   300686
Mailing Address 395 OYSTER POINT BOULEVARD SUITE 400 SOUTH SAN FRANCISCO CA 94080
Business Address 395 OYSTER POINT BOULEVARD SUITE 400 SOUTH SAN FRANCISCO CA 94080 650-266-3500
SUNESIS PHARMACEUTICALS INC (Filer) CIK: 0001061027 (see all company filings)

IRS No.: 943295878 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-51531 | Film No.: 111028353
SIC: 2834 Pharmaceutical Preparations